KUHN v. WILLFORD

CourtDistrict Court, D. New Jersey
DecidedJune 30, 2025
Docket2:24-cv-01123
StatusUnknown

This text of KUHN v. WILLFORD (KUHN v. WILLFORD) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
KUHN v. WILLFORD, (D.N.J. 2025).

Opinion

Not for Publication

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

PETER KUHN,

Civil Action No. 24-1123 (ES) (MAH) Plaintiff, OPINION v.

JOVAN WILLFORD,

Defendant.

SALAS, DISTRICT JUDGE Before the Court is defendant Jovan Willford’s (“Defendant”) motion to dismiss (D.E. No. 14 (“Motion” or “Mot.”)) plaintiff Peter Kuhn’s (“Plaintiff”) Complaint (D.E. No. 1 (“Complaint” or “Compl.”)). Plaintiff filed an opposition (D.E. No. 19 (“Opp. Br.”)), and Defendant filed a reply (D.E. No. 23 (“Reply Br.”)). Having considered the parties’ submissions, the Court decides Defendant’s Motion without oral argument. See Fed. R. Civ. P. 78(b); see also L. Civ. R. 78.1(b). For the following reasons, Defendant’s Motion is GRANTED. I. BACKGROUND A. Factual Background1 Plaintiff is an individual who currently resides in Alabama and who has over twenty-five years of experience in the healthcare technology industry. (Compl. ¶¶ 8 & 12). In December 2020, Plaintiff became the Chief Sales and Growth Officer of Healthgrades. (Id. ¶ 19). Defendant is an individual who currently resides in New Jersey and was hired as the Chief Executive Officer

1 The factual background is taken from the allegations in the Complaint. For purposes of the instant Motion, the Court accepts the factual allegations in the Complaint as true and draws all inferences in the light most favorable to Plaintiff. See Phillips v. Cnty. of Allegheny, 515 F.3d 224, 228 (3d Cir. 2008). (“CEO”) of Healthgrades in March 2021. (Id. ¶¶ 9 & 20). In June 2021, Healthgrades sold its Marketplace division in an asset sale, and, following this divestiture, Mercury Healthcare (“Mercury Healthcare” or the “Company”) was created in July 2021. (Id. ¶¶ 21−22). Shortly thereafter, in August 2021, Plaintiff was promoted to Chief Revenue Officer (“CRO”) of the

Company. (Id. ¶ 26). At some point, Defendant hired A&M Consulting to do a financial review of the remaining business at Mercury Healthcare,2 and “[u]pon information and belief, A&M Consulting immediately discovered that the leftover business at Mercury was losing $30 million annually (a surprise to the Board) and was suffering with major product and customer satisfaction issues on two primary product lines.” (Id. ¶¶ 23−24). Based on A&M Consulting’s recommendations, from August 2021 to December 2021, Plaintiff initiated a cost-cutting plan to reduce sales and certain staff members. (Id. ¶ 31).

From mid-November 2021 through December 2021, Defendant briefly “disappeared” from the Company after presenting a grim financial plan to the Board of Directors, and during this time “there was a rumor of a Board-initiated fire sale spreading through the management team[.]” (Id. ¶ 33). Defendant “suddenly reappear[ed]” in December 2021 and held a meeting with upper management and the executive team members, stating that private equity firm Vestar Capital Partners had agreed to invest up to $30 million in the Company over three years to help fund its turnaround. (Id. ¶ 34). Defendant subsequently presented a five-year plan that included “killing off” two of the Company’s major product lines. (Id. ¶ 35). Plaintiff had concerns about this plan, and at some point following this meeting, he approached Defendant and “asked Defendant if the Company was committed to a turnaround or if it was instead being positioned for a sale.” (Id. ¶

2 The Complaint does not specify when Defendant allegedly hired A&M Consulting, nor when this alleged financial review occurred. (See Compl.). 38). “Defendant assured Plaintiff that the Company was not going to be sold and was focused on executing its [five]-year operating plan[.]” (Id. ¶ 41). “Upon information and belief, and contrary to what Defendant had expressly told Plaintiff, the Company had executed a letter of intent to be sold in December 2021.”3 (Id. ¶ 43).

At some point “[p]rior to December 2021, Defendant learned that the Company intended to sell its assets to WebMD and that plans had been put into place to do so[,]” which “plans included substantial bonuses for the chief executives of the Company.” (Id. ¶ 3). Shortly after Defendant learned about this intended sale, all the other chief officers of the Company—excluding Plaintiff—were also informed of the intended sale. (Id. ¶ 4). From December 2021 through March 2022, Plaintiff had a series of conversations with Defendant regarding the then-current direction of the Company and its effect on the Company’s culture. (Id. ¶ 45). According to Plaintiff, Defendant created a hostile work environment for him during this time by instructing him to make “cold calls” to potential customers and to complete other tasks more frequently reserved for lower-level employees, in an effort to force him to resign.

(Id. ¶¶ 46−49, 52 & 61). Plaintiff was also “uninvited” to the Q4 2021 Board of Directors meeting, and at some point after that meeting he again approached Defendant and asked him if he was planning to sell the Company. (Id. ¶¶ 50 & 53). Defendant again told Plaintiff that the Company was not going to be sold and was committed to a turnaround. (Id. ¶ 53). On March 10, 2022, Plaintiff submitted his resignation notice “[a]s a result of Defendant’s hostile treatment of [him], and in response to Defendant’s stated intent to pursue a fatally flawed turnaround plan[.]” (Id. ¶ 54). Plaintiff’s last day at the Company was April 1, 2022. (Id. ¶ 55).

3 Defendant asserts in his Motion that although he accepts the allegations in the Complaint as true for purposes of this Motion (as he must), he “denies that in December 2021 there was an executed letter of intent to sell the Company.” (D.E. No. 14-1 (“Mov. Br.”) at 8 n.3). Two months later, in June 2022, WebMD announced that it had acquired the Company, though the terms of this deal were not publicly disclosed at the time. (Id. ¶ 56). However, Plaintiff received a notice pursuant to Internal Revenue Code Section 208G that showed multi-million- dollar deal bonus payments made to Defendant and other executive members of the Company. (Id.

¶ 57). Plaintiff alleges that Defendant “intentionally suppressed” certain information from him that caused him to resign from his position as CRO of the Company. (See generally Compl.). Specifically, Plaintiff alleges (i) that Defendant “suppressed” from him the fact that in December 2021 the Company executed a letter of intent to be sold to WebMD; (ii) that, when asked, Defendant told Plaintiff the Company was not going to be sold and instead was committed to a five-year turnaround plan; (iii) that Defendant’s suppression of information, along with the hostile work environment he created for Plaintiff, ultimately induced Plaintiff to resign from the Company, effective April 1, 2022; and (iv) that Plaintiff lost out on a “multi-million dollar” deal bonus as a result of Defendant’s actions. (See id.). Plaintiff states that but for having been

fraudulently misled by Defendant, he would not have resigned and would have “received a multi- million dollar bonus.” (Id. ¶ 6; see also id. ¶¶ 3−4, 38, 41−64 & 66−75). According to Plaintiff, Defendant intended to force him to resign “so that Defendant could avoid paying Plaintiff a deal bonus payout from the sale of the Company to WebMD and instead, keep that money for himself.” (Id. ¶ 63). B. Procedural History On February 27, 2024, Plaintiff initiated this action by filing the Complaint against Defendant, asserting one cause of action titled “Fraudulent Suppression/Deceit.”4 (See generally

4 The Complaint does not identify which state or statute/law governs this cause of action. Compl.).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mayer v. Belichick
605 F.3d 223 (Third Circuit, 2010)
Santiago v. Warminster Township
629 F.3d 121 (Third Circuit, 2010)
In Re: Rockefeller Center Properties, Inc. Securities Litigation, Charal Investment Company Inc., a New Jersey Corporation C.W. Sommer & Co., a Texas Partnership, on Behalf of Themselves and All Others Similarly Situated Alan Freed Jerry Crance Helen Scozzanich Sheldon P. Langendorf Rita Walfield Robert Flashman Renee B. Fisher Foundation Inc. Frank Debora Wilson White Stanley Lloyd Kaufman, Jr. Joseph Gross v. David Rockefeller Goldman Sachs Mortgage Co. Goldman Sachs Group Lp Goldman Sachs & Co. Whitehall Street Real Estate Limited Partnership v. Wh Advisors Inc. v. Wh Advisors Lp v. Daniel M. Neidich Peter D. Linneman Richard M. Scarlata Frank Debora Wilson White Stanley Lloyd Kaufman, Jr. Joseph Gross, Charal Investment Company Inc., a New Jersey Corporation C.W. Sommer & Co., a Texas Partnership, on Behalf of Themselves and All Others Similarly Situated Alan Freed Jerry Crance Helen Scozzanich Sheldon P. Langendorf Rita Walfield Robert Flashman Renee B. Fisher Foundation Inc. Frank Debora Wilson White Stanley Lloyd Kaufman, Jr. Joseph Gross v. David Rockefeller Goldman Sachs Mortgage Co. Goldman Sachs Group Lp Goldman Sachs & Co. Whitehall Street Real Estate Limited Partnership v. Wh Advisors Inc. v. Wh Advisors Lp v. Daniel M. Neidich Peter D. Linneman Richard M. Scarlata Charal Investment Company Inc. C.W. Sommer & Co. Renee B. Fisher Foundation Helen Scozzanich Jerry Crance Alan Freed Sheldon P. Langendorf Rita Walfield Robert Flashman
311 F.3d 198 (Third Circuit, 2002)
Cheryl James v. Wilkes Barre City
700 F.3d 675 (Third Circuit, 2012)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Frederico v. Home Depot
507 F.3d 188 (Third Circuit, 2007)
Jewish Center of Sussex Cty. v. Whale
432 A.2d 521 (Supreme Court of New Jersey, 1981)
Alexander v. Cigna Corp.
991 F. Supp. 427 (D. New Jersey, 1998)
California Natural, Inc. v. Nestle Holdings, Inc.
631 F. Supp. 465 (D. New Jersey, 1986)
Banco Popular North America v. Gandi
876 A.2d 253 (Supreme Court of New Jersey, 2005)
Smajlaj v. Campbell Soup Co.
782 F. Supp. 2d 84 (D. New Jersey, 2011)
Rosenblit v. Zimmerman
766 A.2d 749 (Supreme Court of New Jersey, 2001)
McConkey v. Aon Corp.
804 A.2d 572 (New Jersey Superior Court App Division, 2002)
Gennari v. Weichert Co. Realtors
691 A.2d 350 (Supreme Court of New Jersey, 1997)
Daniel Polhill v. FedEx Ground Package System
604 F. App'x 104 (Third Circuit, 2015)
Travelodge Hotels, Inc. v. Honeysuckle Enterprises Inc.
244 F. App'x 522 (Third Circuit, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
KUHN v. WILLFORD, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kuhn-v-willford-njd-2025.